LEXARIA BIOSCIENCE ($LEXX) posted quarterly earnings results for Q3 2026 on Monday, July 13th. The company reported earnings of -$0.08 per share, beating estimates of -$0.09 by $0.01. The company also reported revenue of $0, missing estimates of $51,000 by $-51,000.
You can see Quiver Quantitative's $LEXX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
LEXARIA BIOSCIENCE Hedge Fund Activity
We have seen 7 institutional investors add shares of LEXARIA BIOSCIENCE stock to their portfolio, and 9 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS GROUP AG removed 308,592 shares (-85.4%) from their portfolio in Q1 2026, for an estimated $240,701
- GEODE CAPITAL MANAGEMENT, LLC added 74,439 shares (+33.9%) to their portfolio in Q1 2026, for an estimated $58,062
- INVENOMIC CAPITAL MANAGEMENT LP removed 28,614 shares (-6.1%) from their portfolio in Q1 2026, for an estimated $22,318
- XTX TOPCO LTD added 25,067 shares (+inf%) to their portfolio in Q1 2026, for an estimated $19,552
- HRT FINANCIAL LP added 18,465 shares (+inf%) to their portfolio in Q1 2026, for an estimated $14,402
- CITADEL ADVISORS LLC added 13,513 shares (+inf%) to their portfolio in Q1 2026, for an estimated $10,540
- OSAIC HOLDINGS, INC. removed 1,590 shares (-72.4%) from their portfolio in Q1 2026, for an estimated $1,240
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
